Cargando…

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia

PURPOSE: A decision-analytic model was developed to study the impact of induction regimens vincristine, adriamycin, dexamethasone (VAD); thalidomide, dexamethasone (TD); and bortezomib, dexamethasone (BorD), followed by autologous stem cell transplantation (ASCT) for treating multiple myeloma (MM) p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qerimi, Vjollca, Nestorovska, Aleksandra Kapedanovska, Sterjev, Zoran, Genadieva-Stavric, Sonja, Suturkova, Ljubica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016005/ https://www.ncbi.nlm.nih.gov/pubmed/29950875 http://dx.doi.org/10.2147/CEOR.S152437

Ejemplares similares

Evaluation of statin utilization in the Republic of Macedonia during 2013–2016
por: Naumovska, Zorica, et al.
Publicado: (2018)

The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome
por: Kapedanovska-Nestorovska, Aleksandra, et al.
Publicado: (2019)

Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia
por: Kapedanovska Nestorovska, A, et al.
Publicado: (2015)

Tretatment Approach of Nontransplant Patients with Multiple Myeloma
por: Krstevska, Svetlana B., et al.
Publicado: (2014)

The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy
por: Sterjev, Zoran, et al.
Publicado: (2012)

Osteonecrosis of the Jaw After Bisphosphonates Treatment in Patients with Multiple Myeloma
por: Krstevska, Svetlana, et al.
Publicado: (2015)

Induction Treatment in Transplant-eligible Multiple Myeloma
por: Quinn, J., et al.
Publicado: (2021)

Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy
por: Sterjev, Z, et al.
Publicado: (2012)

Analysis of Factors that Influence Hematopoietic Recovery in Autologous Transplanted Patients with Hematopoietic Stem Cells from Peripheral Blood
por: Grubovic, Rada M., et al.
Publicado: (2017)

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
por: Bobin, Arthur, et al.
Publicado: (2020)

Reproductive Issues in Long-Term Surviving Patients following Therapy for Hodgkin’s Disease in the Republic of North Macedonia: Risks of Infertility According to First-Line Treatment Regimens
por: Amzai, Gazmend, et al.
Publicado: (2022)

Evaluation of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30, Albanian version) among breast cancer patients from Kosovo
por: Shuleta-Qehaja, Selvete, et al.
Publicado: (2015)

Hairy Cell Leukemia Treatment: Where We Are Now?
por: Krstevska, Svetlana, et al.
Publicado: (2011)

Frequency of Electrocardiographic Changes in Trained Athletes in the Republic of Macedonia
por: Karagjozova, Ivanka, et al.
Publicado: (2017)

How I manage frontline transplant-eligible multiple myeloma in Italy
por: Montefusco, Vittorio, et al.
Publicado: (2020)

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial
por: Jones, John R., et al.
Publicado: (2023)

The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
por: Zamagni, Elena, et al.
Publicado: (2020)

Influence of Prognostic Factors on OverallSurvival in Myelodysplastic Syndromes
por: Sotirova, Tatjana, et al.
Publicado: (2014)

Investigation of Indoor Air Quality in Houses of Macedonia
por: Vilčeková, Silvia, et al.
Publicado: (2017)

Disease in Macedonia
por: Fleming, Robert A.
Publicado: (1919)

The Treatment of Multiple Myeloma Patients Not Eligible for Asct
por: Richardson, Paul, et al.
Publicado: (2010)

PB1993: MULTIPLE MYELOMA BRAZILIAN REGISTER- HOW ABOUT THE TRANSPLANT ELIGIBLE PATIENTS?
por: Crusoe, E., et al.
Publicado: (2022)

30 Years of Improved Survival in Non-Transplant-Eligible Newly Diagnosed Multiple Myeloma
por: Chacon, Aurelia, et al.
Publicado: (2023)

Macedonia : for marimba with piano accompaniment
por: éZivkovi{acute}c, Nebojésa
Publicado: (1987)

Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis
por: Blommestein, Hedwig M., et al.
Publicado: (2019)

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients
por: Matevska-Geshkovska, Nadica, et al.
Publicado: (2018)

Macedonia joins CERN
Publicado: (2009)

Macedonia joins CERN
Publicado: (2009)

Macedonia to cooperate with CERN
Publicado: (2009)

Macedonia in War-Time
Publicado: (1916)

Nature Studies in Macedonia
Publicado: (1916)

Nature Studies in Macedonia
Publicado: (1917)

Bird Life in Macedonia
Publicado: (1917)

Hospital Life in Macedonia
por: Lawrence, Private P. A.
Publicado: (1918)

Antimalarial Work in Macedonia
Publicado: (1918)

Wellbeing in the Republic of Macedonia
por: Oliveira, Nelio
Publicado: (2017)

Predicting ultrahigh risk multiple myeloma by molecular profiling: an analysis of newly diagnosed transplant eligible myeloma XI trial patients
por: Shah, Vallari, et al.
Publicado: (2020)

Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients
por: Panopoulou, Aikaterini, et al.
Publicado: (2023)

P1294: REAL-WORLD OUTCOMES OF 2149 NEWLY DIAGNOSED TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS
por: Popková, Tereza, et al.
Publicado: (2023)

Comparison of anthropometric dimensions of preschool children and chairs in kindergartens in North Macedonia, Bulgaria and Croatia
por: Iliev, Boris, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7agc8kdhdfg8qadpapfdtmutrg